全文获取类型
收费全文 | 4734篇 |
免费 | 620篇 |
国内免费 | 481篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 17篇 |
妇产科学 | 125篇 |
基础医学 | 430篇 |
口腔科学 | 17篇 |
临床医学 | 575篇 |
内科学 | 895篇 |
皮肤病学 | 34篇 |
神经病学 | 213篇 |
特种医学 | 128篇 |
外国民族医学 | 1篇 |
外科学 | 1079篇 |
综合类 | 557篇 |
预防医学 | 241篇 |
眼科学 | 62篇 |
药学 | 775篇 |
2篇 | |
中国医学 | 127篇 |
肿瘤学 | 484篇 |
出版年
2024年 | 23篇 |
2023年 | 231篇 |
2022年 | 295篇 |
2021年 | 350篇 |
2020年 | 409篇 |
2019年 | 242篇 |
2018年 | 229篇 |
2017年 | 178篇 |
2016年 | 205篇 |
2015年 | 241篇 |
2014年 | 508篇 |
2013年 | 364篇 |
2012年 | 546篇 |
2011年 | 449篇 |
2010年 | 290篇 |
2009年 | 250篇 |
2008年 | 228篇 |
2007年 | 272篇 |
2006年 | 139篇 |
2005年 | 107篇 |
2004年 | 65篇 |
2003年 | 43篇 |
2002年 | 34篇 |
2001年 | 21篇 |
2000年 | 24篇 |
1999年 | 20篇 |
1998年 | 9篇 |
1997年 | 15篇 |
1996年 | 16篇 |
1995年 | 14篇 |
1994年 | 3篇 |
1993年 | 5篇 |
1992年 | 3篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 1篇 |
排序方式: 共有5835条查询结果,搜索用时 37 毫秒
1.
2.
Keyang Qian Hanqing Qian Juan Cai Wuheng Yue Xiaoxiao Yu Baorui Liu 《Pathology, research and practice》2019,215(4):755-760
Gastric cancer, one of the most common disease, has become a major public health problem worldwide. Cisplatin (DDP) has been a widely used drug for the treatment of cancer, also usually applied in gastric cancer in clinic. However, the side effects including toxicity and drug-resistance restricted the usage of DDP in clinic, so we prepared a DDP-complexed hydrogel (DDP-Gel) and investigated its efficacy in gastric cancer. For in vivo studies, MKN45-Luc cells were injected into BLAB/C node mice subcutaneously to establish gastric cancer with orthotopically grown tumors. Mice bearing tumors were treated with normal saline, DDP and DDP-Gel. Body weight and survival condition were observed and recorded. The treatment efficacy in vivo was detected by luciferase imaging and histological evaluation was performed by H&E staining of different organs. Additionally, normal ICR mice were treated with different doses of DDP/DDP-Gel to calculate their LD50 in vivo. The results showed that DDP-Gel prolonged survival time and ameliorated body weight changes of mice bearing tumors. DDP-Gel exhibited higher efficacy to inhibit tumor growth and metastasis, compared to DDP. Besides, LD50 of DDP-Gel was 166.0?mg/kg, 13.2 folds higher than DDP. As a conclusion, DDP-Gel showed a more effective and safer function than DDP in gastric cancer, which indicating that DDP-Gel might be a novel strategy for gastric cancer therapy. 相似文献
3.
4.
5.
Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) are a new type of drug for the treatment of diabetes, and they have been proven to have a good hypoglycemic effect. Several lines of clinical evidence have shown that SGLT2 inhibitors can significantly reduce the risks of atherosclerosis, hospitalization for heart failure, cardiovascular death, and all-cause mortality and delay the progression of chronic kidney disease. Because of the protective effects of SGLT2 inhibitors on the heart and kidney, they are being studied for the treatment of heart failure and chronic kidney disease in patients without diabetes. Therefore, it is necessary for cardiologists, patients with diabetes, and nephrologists to fully understand this type of drug. In this review, we summarize the following three aspects of SGLT2 inhibitors: the recent clinical evidence of their cardiovascular benefits, their mechanisms of action, and their safety. 相似文献
6.
7.
Pyroptosis pathway is closely related to inflammation. However, Celastrol effect on pyroptosis pathway after spinal cord injury (SCI) are poorly understood. We studied the anti-inflammatory and neuroprotective effects of Celastrol on acute spinal cord injury in rats, and its anti-inflammatory effects on lipopolysaccharide (LPS)/ATP-induced microgliosis. Our results show that Celastrol can improve the recovery of hindlimb motor function after SCI in Sprague-Dawley (SD) rats, and reduce the cavity area of spinal cord injury along with the neuronal loss. Celastrol simultaneously reduced the activation of microglia (especially M1 microglia) in the spinal cord, inhibited the pyroptosis-related proteins (NLRP3 ASC Caspase-1 GSDMD), reduced the release of TNF-α IL-1β and IL-18 inflammatory factors, and increased the release of IL10 cytokines. In vitro studies showed that Celastrol reduced the toxicity resulting from the administration of LPS with ATP to BV-2 cells, inhibited the pyroptosis-related proteins (NLRP3 Caspase-1 GSDMD), and inhibited the release of corresponding inflammatory factors. Finally, Celastrol can inhibit the expression of NFκB/p-p65 in vitro and in vivo. Our results show that Celastrol can attenuate the inflammatory response of the spinal cord after SCI, which is associated with inhibition of microglial activation and pyroptosis pathway. Further study to explore the use of Celastrol to treat SCI is warranted. 相似文献
8.
Wan-Jie Gu 《Journal of thoracic disease》2015,7(11):1885-1886
It is well known that a meta-analysis of randomized controlled trials aims to increase the power and precision of the estimated intervention effects. However, when a meta-analysis includes a limited number of patients and a small number of events, overestimation of intervention effect estimates may occur and could cause spurious results. Although many biases can cause the overestimation, random error may be the most common cause. Trial sequential analysis (TSA) can explore the independent effect of random error on intervention effect estimates in meta-analyses and protect meta-analyses against overestimation due to random error. 相似文献
9.
10.
肝移植术后糖尿病危险因素分析 总被引:2,自引:0,他引:2
目的 探讨肝移植术后糖尿病(PTDM)的发生及发展的危险因素。方法 回顾性分析98例肝移植受者的临床资料。根据其肝移植术后是否发生糖尿病,分为糖尿病组(36例)和非糖尿病组(62例)。以术前和术后可能的9个危险因素作为分析指标,进行这些指标的单因素分析和χ^2检验。结果 在对两组患者的年龄、乙型肝炎病毒(HBV)感染情况、有无肝硬化及肝硬化的程度、术前糖耐量情况、免疫抑制剂的选择及其血药浓度、激素的使用时间的比较分析中发现:术前肝硬化患者PTDM的发生率明显高于无肝硬化者;肝硬化失代偿期患者PTDM的发生率高于代偿期。术前糖耐量异常的患者PTDM的发生率明显高于糖耐量正常者。激素半年内撤离的患者PTDM的发生率明显低于半年内未撤离者。而两组患者的年龄、HBV的感染情况、免疫抑制剂的选择及其血药浓度相比较,差异均无统计学差异。结论 肝硬化、尤其是肝硬化失代偿期,糖耐量异常,长期使用激素是PTDM发生的危险因素。 相似文献